Symptom Severity Reduction and QoL Improvement With Avapritinib in Indolent Systemic Mastocytosis Through 4 Years (ACAAI 2026) - Sep 12, 2026 - Pres time: Nov 14, 2026; 05:13 PM - 05:23 PM; Location: Room 124, Phoenix Convention Center; No abstract available
Late-breaking abstract
|